MedTrace Logo

Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal

NCT05738109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2024-06-14

No results posted yet for this study

Summary

1. Does a 91-day self-talk journal intervention improve outcomes of self-criticism, self-esteem, automatic negative self-statements, and mental health among participants using the journal over wait-list control?
2. What is the adherence rate to a 91-day self-talk journal intervention?
3. What were participants' experience(s) of using a 91-day self-talk journal?

Conditions

Interventions

OTHER

Self-Talk Journals

Participants randomized to the intervention group will receive a physical copy of the 91-day self-talk journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Intervention participants will not be offered guidance or feedback on the journal after these initial instructions, in order to emulate an ad libitum usage. Control group participants will not receive any contact with the researchers outside of the planned questionnaires and to receive their journal at the three-month timepoint.

Sponsors & Collaborators

  • Switch Research

    collaborator UNKNOWN

  • Mathematics of Information Technology and Complex Systems

    collaborator UNKNOWN

  • University of Victoria

    lead OTHER

Principal Investigators

  • Ryan Rhodes, PhD · Lab Director and Professor

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-13
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05738109 on ClinicalTrials.gov